相关实验视频

Updated: Jul 2, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

在帕金森病中,Ndfip1通过调节线粒体功能和铁死来保护多巴胺类神经元

Xiaomin Fu¹, Le Qu¹, Huamin Xu¹

¹Institute of Brain Science and Disease, School of Basic Medicine, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Qingdao University, Qingdao 266021, China.

Experimental neurology

|February 16, 2024

概括

Nedd4家族交互蛋白1 (Ndfip1) 通过保护多巴胺基神经元,防止帕金森病 (PD). 在PD模型中,过度表达Ndfip1可以改善运动功能,并通过VDAC调节和ferroptosis抑制来对抗神经毒性.

科学领域:

神经科学是一个神经科学.
细胞生物学细胞生物学
生物化学生化学

背景情况:

线粒体功能障碍和铁积累与帕金森病 (PD) 病原发生有关.
Nedd4家族相互作用蛋白1 (Ndfip1) 是一种适应蛋白,在PD细胞模型中曾经观察到神经保护作用.
在PD动物模型中Ndfip1的体内神经保护作用和机制在很大程度上是未知的.

研究的目的:

在体内使用帕金森病小鼠模型研究Ndfip1的神经保护作用.
阐明 Ndfip1 介导的神经保护的潜在机制,重点关注电压依赖的阴离子选择通道 (VDAC) 和铁死.

主要方法:

利用1-甲基-4--1,2,3,6-四胺 (MPTP) 的小鼠模型来诱导帕金森病.
评估了 substantia nigra (SN) 中的运动功能和多巴胺基神经元损失.
使用MPP+诱导的SH-SY5Y细胞研究Ndfip1对VDAC,线粒体功能和铁亡标记物的影响.

主要成果:

在MPTP诱导的PD小鼠的SN中,Ndfip1表达减少.
在接受MPTP治疗的小鼠中,过度表达Ndfip1显著改善了运动功能,并保护了多巴胺类神经元.
Ndfip1过度表达抑制了MPP+诱导的VDAC1/2上调,恢复了线粒体功能,并通过降低SH-SY5Y细胞中ACSL4的调节来预防铁亡.

结论:

在活体帕金森病模型中,ndfip1对多巴胺能神经元表现出显著的神经保护作用.
Ndfip1通过调节VDAC表达和减轻铁亡来发挥其保护作用.
Ndfip1代表了帕金森病和其他与铁有关的神经退行性疾病的有前途的治疗标.

关键词:

铁化是铁化的一种.铁铁铁是什么意思铁铁铁线粒体功能障碍线粒体功能障碍帕金森病的疾病.取决于电压的离子选择性通道.

更多相关视频

Primary Culture of Mouse Dopaminergic Neurons

Primary Culture of Mouse Dopaminergic Neurons

Published on: September 8, 2014

Author Spotlight: Fluorescence-Based Quantification of Mitochondrial Membrane Potential and Superoxide Levels Using Live Imaging in HeLa Cells

Author Spotlight: Fluorescence-Based Quantification of Mitochondrial Membrane Potential and Superoxide Levels Using Live Imaging in HeLa Cells

Published on: May 12, 2023

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Translocation of Proteins into the Mitochondria

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...

Drugs Affecting Neurotransmitter Synthesis

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...